Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 90042W100 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
|
FMR LLC
13G/A
|
4.9% |
5/12/2025
Event 3/31/2025
|
||
| FMR LLC | 4.9% | |||
| Abigail P. Johnson | 4.9% | |||
|
Point72 Asset Management, L.P.
13G/A
|
0% |
11/14/2025
Event 9/30/2025
|
||
| Point72 Asset Management, L.P. | 0% | |||
| Point72 Capital Advisors, Inc. | 0% | |||
| Point72 Biotech Private Investments, LLC | 0% | |||
| Differentiated Ventures Investments, LLC | 0% | |||
| 72 Investment Holdings, LLC | 0% | |||
| Steven A. Cohen | 0% | |||
|
Versant Venture Capital V, L.P.
13D/A
|
0% |
8/12/2025
Event 8/8/2025
|
||
| Versant Venture Capital V, L.P. | 0% | |||
| Versant Affiliates Fund V, L.P. | 0% | |||
| Versant Ophthalmic Affiliates Fund I, L.P. | 0% | |||
| Versant Ventures V, LLC | 0% | |||
| Versant Venture Capital V (Canada) LP | 0% | |||
| Versant Ventures V GP-GP (Canada), Inc. | 0% | |||
| Versant Ventures V (Canada), L.P. | 0% | |||
| Versant Vantage II, L.P. | 0% | |||
| Versant Vantage II GP, L.P. | 0% | |||
| Versant Vantage II GP-GP, LLC | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q3 | 1 | 40.4 k | $0 |
| 2025 Q2 | 24 | 8.43 M | $3.03 M |
| 2025 Q1 | 24 | 10.4 M | $4.26 M |
| 2024 Q4 | 29 | 11.1 M | $5.51 M |
| 2024 Q3 | 26 | 11.4 M | $6.37 M |
| 2024 Q2 | 50 | 12.7 M | $33.3 M |
| 2024 Q1 | 44 | 13.4 M | $35.1 M |
| 2023 Q4 | 39 | 13.0 M | $33.2 M |
| 2023 Q3 | 36 | 12.2 M | $48.0 M |